- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
XOMA Market Currents
more »
XOMA Related Articles
more »
XOMA News
more »
-
at MarketWatch.com (Mar 23, 2011)
-
at MarketWatch.com (Mar 23, 2011)
-
at MarketWatch.com (Mar 23, 2011)
-
at MarketWatch.com (Mar 22, 2011)
-
at MarketWatch.com (Jan 6, 2011)
XOMA Press Releases and Filings
more »
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (May 1, 2012)
-
GlobeNewswire (Apr 24, 2012)
-
GlobeNewswire (Mar 14, 2012)
-
GlobeNewswire (Jan 5, 2012)
XOMA Latest Transcript
more »
-
Tue, May 8Popular searches: patients.
XOMA Cramer
more »
Currently, there are no Cramer articles on XOMA.
XOMA Instablog posts
more »
XOMA vs. ETF Alternatives
Company Description
XOMA Ltd. (“XOMA”), a Bermuda company, is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies designed to treat inflammatory, autoimmune, infectious and oncological diseases. Our proprietary development pipeline includes XOMA 052, an... More